← Leaderboards
Sharon Demorrow
Scott And White Memorial Hospital
$5,978,090
Attributed
$5,978,090
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $711.3K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,978,090 · 5
VA$0 · 1
By mechanism
R01$5,146,869 · 3
K01$697,309 · 1
R03$133,912 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignBaseMediatingTreatment StrategyPathway InteractionsEffective TherapyBrainLiverHepatic EncephalopathySignal TransductionRodent ModelResponseLaboratoriesLeadBile DuctCholangiocyteTherapeutic DevelopmentBiliaryProgramsPlayLiver DiseasesLiver InjuryHormonesChronic
Grant awards (30)
Role of cholesterol in the pathogenesis of hepatic encephalopathy$558,484
R01 · FY2025 · DK · contact PI
Role of cholesterol in the pathogenesis of hepatic encephalopathy$556,767
R01 · FY2024 · DK · contact PI
Molecular mechanisms of drug-induced liver injury$356,460
R01 · FY2021 · DK · contact PI
Molecular mechanisms of drug-induced liver injury$356,460
R01 · FY2020 · DK · contact PI
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasia$354,874
R01 · FY2020 · DK · contact PI
Molecular mechanisms of drug-induced liver injury$356,460
R01 · FY2019 · DK · contact PI
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasia$354,874
R01 · FY2019 · DK · contact PI
Molecular mechanisms of drug-induced liver injury$290,588
R01 · FY2018 · DK · contact PI
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasia$284,522
R01 · FY2018 · DK · contact PI
The role of hypothalamic neuropeptides on biliary function during cholestasis$0
I01 · FY2018 · VA · contact PI
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasia$286,652
R01 · FY2017 · DK · contact PI
The role of hypothalamic neuropeptides on biliary function during cholestasis$0
I01 · FY2017 · VA · contact PI
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasia$286,734
R01 · FY2016 · DK · contact PI
The role of hypothalamic neuropeptides on biliary function during cholestasis$0
I01 · FY2016 · VA · contact PI
The role of hypothalamic neuropeptides on biliary function during cholestasis$0
I01 · FY2015 · VA · contact PI
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia$207,068
R01 · FY2014 · DK · contact PI
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia$199,821
R01 · FY2013 · DK · contact PI
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia$207,068
R01 · FY2012 · DK · contact PI
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia$204,932
R01 · FY2011 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$126,973
K01 · FY2011 · DK · contact PI
The Role of Progranulin in Cholangiocarcinoma Growth$62,370
R03 · FY2011 · DK · contact PI
Dysregulated Hypothalamic-pituitary-adrenal Axis During Biliary Hyperplasia$285,105
R01 · FY2010 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$126,973
K01 · FY2010 · DK · contact PI
The Role of Progranulin in Cholangiocarcinoma Growth$71,542
R03 · FY2010 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$126,973
K01 · FY2009 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$53,950
K01 · FY2009 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$1,080
K01 · FY2009 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$126,973
K01 · FY2008 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$3,707
K01 · FY2008 · DK · contact PI
Endocannabinoid Regulation of Cholangiocarcinoma Cell Growth$130,680
K01 · FY2007 · DK · contact PI